132 related articles for article (PubMed ID: 19505085)
21. Tubedown expression correlates with the differentiation status and aggressiveness of neuroblastic tumors.
Martin DT; Gendron RL; Jarzembowski JA; Perry A; Collins MH; Pushpanathan C; Miskiewicz E; Castle VP; Paradis H
Clin Cancer Res; 2007 Mar; 13(5):1480-7. PubMed ID: 17332292
[TBL] [Abstract][Full Text] [Related]
22. The Gem GTP-binding protein promotes morphological differentiation in neuroblastoma.
Leone A; Mitsiades N; Ward Y; Spinelli B; Poulaki V; Tsokos M; Kelly K
Oncogene; 2001 May; 20(25):3217-25. PubMed ID: 11423971
[TBL] [Abstract][Full Text] [Related]
23. Glycopeptides from the surgace of human neuroblastoma cells.
Glick MC; Schlesinger H; Hummeler K
Cancer Res; 1976 Dec; 36(12):4520-4. PubMed ID: 1000497
[TBL] [Abstract][Full Text] [Related]
24. Immune modulator CD70 as a potential cisplatin resistance predictive marker in ovarian cancer.
Aggarwal S; He T; Fitzhugh W; Rosenthal K; Feild B; Heidbrink J; Mesmer D; Ruben SM; Moore PA
Gynecol Oncol; 2009 Dec; 115(3):430-7. PubMed ID: 19800108
[TBL] [Abstract][Full Text] [Related]
25. Newer vascular targets: endosialin (review).
Teicher BA
Int J Oncol; 2007 Feb; 30(2):305-12. PubMed ID: 17203210
[TBL] [Abstract][Full Text] [Related]
26. Estimation of diagnostic value of chosen markers of neural differentiation in neuroblastoma group of tumors and pPNETs.
Sałacińska-Łoś E; Kobos J; Taran K
Pol J Pathol; 2008; 59(4):195-9. PubMed ID: 19391485
[TBL] [Abstract][Full Text] [Related]
27. Vasoactive intestinal peptide-induced neuritogenesis in neuroblastoma SH-SY5Y cells involves SNAP-25.
Héraud C; Chevrier L; Meunier AC; Muller JM; Chadéneau C
Neuropeptides; 2008; 42(5-6):611-21. PubMed ID: 18617262
[TBL] [Abstract][Full Text] [Related]
28. [Phosphorylated membrane proteome analysis of human neuroblastoma SH-SY5Y cell line].
Hou C; Ma J; Tao D; Zhang L; Liang Z; Zhang Y
Se Pu; 2011 Sep; 29(9):851-6. PubMed ID: 22233071
[TBL] [Abstract][Full Text] [Related]
29. Cyclin D1 in pediatric neuroblastic tumors: A microarray analysis.
Fagone P; Nicoletti F; Vecchio GM; Parenti R; Magro G
Acta Histochem; 2015 Oct; 117(8):820-3. PubMed ID: 26510683
[TBL] [Abstract][Full Text] [Related]
30. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication.
Yu W; Liu J; Xiong X; Ai Y; Wang H
Pathol Res Pract; 2009; 205(10):709-15. PubMed ID: 19541433
[TBL] [Abstract][Full Text] [Related]
31. Ras protein expression and autophagic tumor cell death in neuroblastoma.
Kitanaka C; Kato K; Tanaka Y
Am J Surg Pathol; 2007 Jan; 31(1):153-5; author reply 155-7. PubMed ID: 17197932
[No Abstract] [Full Text] [Related]
32. Qualitative and quantitative proteomic profiling of cripto(-/-) embryonic stem cells by means of accurate mass LC-MS analysis.
Chambery A; Vissers JP; Langridge JI; Lonardo E; Minchiotti G; Ruvo M; Parente A
J Proteome Res; 2009 Feb; 8(2):1047-58. PubMed ID: 19152270
[TBL] [Abstract][Full Text] [Related]
33. Cell renewing in neuroblastoma: electrophysiological and immunocytochemical characterization of stem cells and derivatives.
Biagiotti T; D'Amico M; Marzi I; Di Gennaro P; Arcangeli A; Wanke E; Olivotto M
Stem Cells; 2006 Feb; 24(2):443-53. PubMed ID: 16100002
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of the membrane proteome of closely related metastatic and nonmetastatic tumor cells.
Roesli C; Borgia B; Schliemann C; Gunthert M; Wunderli-Allenspach H; Giavazzi R; Neri D
Cancer Res; 2009 Jul; 69(13):5406-14. PubMed ID: 19491280
[TBL] [Abstract][Full Text] [Related]
35. Interfacing SH-SY5Y human neuroblastoma cells with SU-8 microstructures.
Wu ZZ; Zhao Y; Kisaalita WS
Colloids Surf B Biointerfaces; 2006 Sep; 52(1):14-21. PubMed ID: 16837176
[TBL] [Abstract][Full Text] [Related]
36. The novel chimeric anti-NCAM (neural cell adhesion molecule) antibody ch.MK1 displays antitumor activity in SCID mice but does not activate complement-dependent cytolysis (CDC).
Klehr M; Koehl U; Mühlenhoff M; Tawadros S; Fischer T; Schomäcker K; Heuckmann JM; Bochennek K; Jensen M
J Immunother; 2009 Jun; 32(5):442-51. PubMed ID: 19609236
[TBL] [Abstract][Full Text] [Related]
37. Membrane-enriched proteome changes and prion protein expression during neural differentiation and in neuroblastoma cells.
Macedo JA; Schrama D; Duarte I; Tavares E; Renaut J; Futschik ME; Rodrigues PM; Melo EP
BMC Genomics; 2017 Apr; 18(1):319. PubMed ID: 28431525
[TBL] [Abstract][Full Text] [Related]
38. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM
J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612
[TBL] [Abstract][Full Text] [Related]
39. Effects of exposure to DAMPS and GSM signals on ornithine decarboxylase (ODC) activity: II. SH-SY5Y human neuroblastoma cells.
Billaudel B; Taxile M; Poulletier de Gannes F; Ruffie G; Lagroye I; Veyret B
Int J Radiat Biol; 2009 Jun; 85(6):519-22. PubMed ID: 19440939
[TBL] [Abstract][Full Text] [Related]
40. The TRPM7 interactome defines a cytoskeletal complex linked to neuroblastoma progression.
Middelbeek J; Vrenken K; Visser D; Lasonder E; Koster J; Jalink K; Clark K; van Leeuwen FN
Eur J Cell Biol; 2016 Nov; 95(11):465-474. PubMed ID: 27402209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
